Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Juliusson, Gunnar; Antunović, Petar; Rangert Derolf, Åsa; Lehmann, Sören; Möllgård, Lars; Stockelberg, Dick; Tidefelt, Ulf; Wåhlin, Anders; Höglund, Martin

doi:10.1182/blood-2008-07-172007

Public

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Published in Blood • Nov 13, 2008

Authors:

Gunnar Juliusson

Petar Antunović

Åsa Rangert Derolf

Abstract

Acute myeloid leukemia (AML) is most common in the elderly, and most elderly are thought to be unfit for intensive treatment because of the risk of fatal toxicity. The Swedish Acute Leukemia Registry covers 98% of all patients with AML (nonacute promyelocytic leukemia) diagnosed in 1997 to 2005 (n =...

Subject

Medicine

Myeloid leukemia

Intensive care

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!